GlassScriptPhysician profile
Charles Jonathan Lyerly
NPI 1104443100
$4,138.79
in general payments reported to CMS, 2019-2025
20 companies · $615 in 2025
The $615 reported for 2025 was more than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $960 · 2021: $588 · 2022: $537 · 2023: $1,375 · 2024: $63.46 · 2025: $615.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,175 · Travel and Lodging: $878.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,175.29 |
| Travel and Lodging | $878.23 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Orthofix Medical, INC. | $1,108.87 | 2023 | Truelok |
| Liberty Surgical INC. | $959.57 | 2020 | |
| Organogenesis INC. | $652.51 | 2021-2022 | |
| Stryker Corporation | $321.88 | 2022-2025 | Prostep, Ortholoc 2 Lapifuse, Sonicanchor |
| Nevro Corp. | $182.28 | 2022-2023 | Senza |
| Globus Medical, INC. | $174.50 | 2025 | Omnia, Senza |
| Zimmer Biomet Holdings, INC. | $161.75 | 2021 | |
| Smith+Nephew, INC. | $110.94 | 2021-2025 | Collagenase Santyl, Grafix Pl, Regranex |
| Paratek Pharmaceuticals, INC. | $90.38 | 2023 | Nuzyra |
| Peerless Surgical INC. | $72.32 | 2025 | |
| Vertex Pharmaceuticals Incorporated | $50.60 | 2025 | |
| Integra Lifesciences Corporation | $46.04 | 2025 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Acera Surgical, INC. | $41.80 | 2022 | |
| Medtronic, INC. | $32.39 | 2025 | Inceptiv |
| Ibsa Pharma INC. | $24.17 | 2023 | Tirosint, Licart |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mimedx Group, INC. | $24.10 | 2024 | |
| Bioventus LLC | $24.01 | 2024 | Exogen Ultrasound Bone Healing System |
| Amgen INC. | $23.20 | 2025 | Krystexxa |
| Kci USA, INC. | $20.68 | 2022 | |
| Treace Medical Concepts, INC. | $16.80 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Charles Lyerly listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.